Cullman Clinical Trials | Cullman, AL

Research site

Location

501 Clark Street North East, Cullman, Alabama, United States of America

Site insights

Top conditions

Top treatments

Bimagrumab

Cenicriviroc

Naltrexone Hydrochloride

Bupropion Hydrochloride

AZD7442

AXA1125

Semaglutide

Zotatifin

SNG001

LY3437943

Data sourced from clinicaltrials.gov

Active trials

8 of 26 total trials

A Study of Retatrutide (LY3437943) in Participants With Type 2 Diabetes Mellitus Who Have Obesity or Overweight (TRIUMPH-2)

The purpose of this study is to is to evaluate the efficacy and safety of retatrutide in participants with type 2 diabetes in participants who have o...

Enrolling

Overweight

Obesity

Drug: Placebo

Drug: Retatrutide

A Study to Learn About the Study Medicine Sisunatovir in Adults With Respiratory Syncytial Virus (RSV) Infection

The purpose of this study is to learn about the safety and effects of sisunatovir. Sisunatovir is studied for the possible treatment of Respiratory S...

Enrolling

Respiratory Syncytial Virus Infection

Drug: Placebo

Drug: Sisunatovir

Dose-Finding Study Evaluating Effect on Body Composition of Enobosarm in Patients Taking a GLP-1 for Chronic Weight Mgmt (QUALITY)

The primary objective of this study is to assess the effect of enobosarm on total lean mass as measured by DEXA in patients maintained on GLP-1 recep...

Enrolling

Obesity

Muscle Loss

Drug: Semaglutide

Drug: Enobosarm

Effect of Naltrexone Hydrochloride ER and Bupropion Hydrochloride ER Combination (Contrave®/Mysimba®) on Major Adverse Cardiovascular Events (MACE) (INFORMUS)

A randomized, double-blinded, placebo controlled study intended to capture cardiovascular outcomes during real-world use of naltrexone/bupropion (NB).

Enrolling

Obesity

Drug: Placebo

Drug: Naltrexone-Bupropion (NB) Combination

Proof of Principle Study to Evaluate the Safety, PK, Viral Shedding and Efficacy of Pentarlandir™ UPPTA for Patients With Early COVID-19

This is a clinical trial to evaluate the safety, PK, viral shedding and clinical effects of Pentarlandir™ UPPTA in patients with early COVID-19. Appr...

Enrolling

Coronavirus Disease 2019

Drug: Pentarlandir™ UPPTA

Drug: Placebo

Safety and Efficacy of Bimagrumab and Semaglutide in Adults Who Are Overweight or Obese

A phase 2 study to assess the efficacy of bimagrumab alone or in addition to semaglutide to assess efficacy and safety in overweight or obese men and...

Active, not recruiting

Overweight or Obesity

Obese

Drug: Semaglutide

Biological: Bimagrumab

Safety, Tolerability, and Efficacy of AXA1125 in NASH With Fibrosis

This study will compare the effects of AXA1125, an orally active mixture of amino acids, compared to placebo, on improving fat and inflammation (stea...

Enrolling

Non Alcoholic Steatohepatitis (NASH)

Drug: AXA1125

Drug: Placebo

Study to Evaluate Safety and Immunogenicity of Different Priming and Booster Regimens With Adjuvanted H5N8 and/or H5N6 Influenza Vaccine in Adults

This Phase 2, randomized, observer-blind clinical study is evaluating 3 different priming and booster regimens with MF59-adjuvanted H5N8 and/or H5N6...

Active, not recruiting

Influenza, Human

Infection Viral

Biological: aH5N6c on Day 1

Biological: aH5N8c on Day 202